A new study reports nitrous oxide is showing promise as an effective treatment for depression.
Researchers report a single dose of a widely prescribed antidepressant causes quantifiable changes in the brain within a matter of hours.
Researchers report administering cannabinoids soon after a traumatic event can prevent PTSD-like symptoms in rats.
Researchers identify a molecular pathway which accelerates the time taken for antidepressants to work in mouse models.
Researchers suggest serotonin metabolism in the pineal gland could play a role in the underlying cause of depression. The findings were based on biochemical changes which were seen to be in association with improvements in depression.
A synthetic compound, decynium-22, is able to turn off SERT in the brain, enhancing the effectiveness of SSRIs.
A new study funded by the NIMH suggests GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the negative side effects of the well known street drug.